Document is current
Any future updates will be listed below
-
Authors
Nelles, Christian
Gräf, Moritz
Bernard, Pascale
Persigehl, Thorsten
Große Hokamp, Nils
Zopfs, David
Maintz, David
Kreuzberg, Nicole
Wolf, Jürgen
Bröckelmann, Paul J.
Lennartz, Simon https://orcid.org/0000-0002-3254-4809
-
Funding
Funding for this research was provided by:
Else Kröner-Fresenius-Stiftung (EKEA-66)
- License Information
-
More Information
Article History
Received: 12 April 2024
Revised: 12 July 2024
Accepted: 18 August 2024
First Online: 18 September 2024
Compliance with ethical standards
:
: The scientific guarantor of this publication is Simon Lennartz.
: The authors of this manuscript declare relationships with the following companies: Nils Große Hokamp: Research support from Philips Healthcare; speakers bureau of Philips Healthcare and Amboss GmbH; Consultant to Bristol-Myers Squibb and BeiGene, David Zopfs: Research support from Philips Healthcare, Jürgen Wolf: Has received payments or honoraria, has received support for attendings meetings and travel, and has participated in a Data Safety Monitoring Board or Advisory Board, from Amgen, AstraZeneca, Bayer, Blueprint, BMS, Boehringer-Ingelheim, Chugai, Daiichi Sankyo, Janssen, Lilly, Loxo, Merck, Mirati, MSD, Novartis, Nuvalent, Pfizer, Pierre-Fabre, Roche, Seattle Genetics, Takeda, and Turning Point, Paul Bröckelmann: Grants (institutional) from BeiGene, Bristol-Myers Squibb, Merck Sharp and Dohme, and Takeda; consulting fees from Takeda; honoraria from BeiGene, Merck Sharp and Dohme, and Takeda; travel/meeting support from Celgene, Simon Lennartz: Authorship and speaker fees, Amboss GmbH.
: One of the authors has significant statistical expertise.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was obtained.
: None.
:
